Imaging Biometrics Ltd. (LON:IBAI)

Market Cap	1.30M -38.2%
Revenue (ttm)	788.15K +5.1%
Net Income	-400.94K
EPS	-0.00
Shares Out	246.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	319,068
Average Volume	226,801
Open	0.5200
Previous Close	0.5250
Day's Range	0.4750 - 0.6000
52-Week Range	0.4000 - 1.4000
Beta	0.89
RSI	32.90
Earnings Date	May 27, 2026

About Imaging Biometrics

Imaging Biometrics Ltd., through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, Switzerland, European Union, and the United States. It operates through Holding Company, Medical Software, and Oral Gallium Maltolate (GaM) segments. The company develops ready-to-use software applications for the healthcare industry comprising IB Clinic for all IB software platforms; IB Neuro, a MR DSC perfusion processing platform; IB Delta Suite, which creates Delta T1 maps from routin...

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 1965
• Employees: 7
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IBAI

Financial Performance

In 2025, Imaging Biometrics's revenue was 788,148, an increase of 5.07% compared to the previous year's 750,105. Losses were -400,940, 22.6% more than in 2024.